Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steckler

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Acta Neurologica Belgica|December 26, 2014
In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptorsStefanie Dedeurwaerdere, Stephanie Boets, Pieter Janssens, et al.
Current Topics in Behavioral Neurosciences|February 11, 2011
Metabotropic glutamate receptors: their therapeutic potential in anxietyWill Spooren, Anne Lesage, Hilde Lavreysen, et al.
Journal of Biopharmaceutical Statistics|March 31, 2005
A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependentZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2008
Removing obstacles in neuroscience drug discovery: the future path for animal modelsAthina Markou, Christian Chiamulera, Mark A Geyer, et al.
Psychopharmacology|May 28, 2015
Opposing effects of glutamatergic and GABAergic pharmacological manipulations on a visual perception task with relevance to schizophreniaJohn C Talpos, John Riordan, Joseph Olley, et al.
Journal of Biopharmaceutical Statistics|September 8, 2017
A HIERARCHICAL BINOMIAL-POISSON MODEL FOR THE ANALYSIS OF A CROSSOVER DESIGN FOR CORRELATED BINARY DATA WHEN THE NUMBER OF TRIALS IS DOSE-DEPENDENTZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Trends in Pharmacological Sciences|November 11, 2003
Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersAndrew Holmes, Markus Heilig, Nadia M J Rupniak, et al.
Current Topics in Behavioral Neurosciences|February 11, 2011
Pharmacologic treatment of panic disorderMurray Stein, Thomas Steckler, Jeffrey D Lightfoot, et al.
The European Journal of Neuroscience|July 9, 2002
Effects of transgenic overproduction of CRH on anxiety-like behaviourMarcel M van Gaalen, Mary P Stenzel-Poore, Florian Holsboer, et al.
The European Journal of Neuroscience|July 30, 2016
Do wholes become more than the sum of their parts in the rodent (Rattus Norvegicus) visual system? A test case with the configural superiority effectJohn C Talpos, Lee de-Wit, Joseph Olley, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Acta Neurologica Belgica|December 26, 2014
In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptorsStefanie Dedeurwaerdere, Stephanie Boets, Pieter Janssens, et al.
Current Topics in Behavioral Neurosciences|February 11, 2011
Metabotropic glutamate receptors: their therapeutic potential in anxietyWill Spooren, Anne Lesage, Hilde Lavreysen, et al.
Journal of Biopharmaceutical Statistics|March 31, 2005
A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependentZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2008
Removing obstacles in neuroscience drug discovery: the future path for animal modelsAthina Markou, Christian Chiamulera, Mark A Geyer, et al.
Psychopharmacology|May 28, 2015
Opposing effects of glutamatergic and GABAergic pharmacological manipulations on a visual perception task with relevance to schizophreniaJohn C Talpos, John Riordan, Joseph Olley, et al.
Journal of Biopharmaceutical Statistics|September 8, 2017
A HIERARCHICAL BINOMIAL-POISSON MODEL FOR THE ANALYSIS OF A CROSSOVER DESIGN FOR CORRELATED BINARY DATA WHEN THE NUMBER OF TRIALS IS DOSE-DEPENDENTZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Trends in Pharmacological Sciences|November 11, 2003
Neuropeptide systems as novel therapeutic targets for depression and anxiety disordersAndrew Holmes, Markus Heilig, Nadia M J Rupniak, et al.
Current Topics in Behavioral Neurosciences|February 11, 2011
Pharmacologic treatment of panic disorderMurray Stein, Thomas Steckler, Jeffrey D Lightfoot, et al.
The European Journal of Neuroscience|July 9, 2002
Effects of transgenic overproduction of CRH on anxiety-like behaviourMarcel M van Gaalen, Mary P Stenzel-Poore, Florian Holsboer, et al.
The European Journal of Neuroscience|July 30, 2016
Do wholes become more than the sum of their parts in the rodent (Rattus Norvegicus) visual system? A test case with the configural superiority effectJohn C Talpos, Lee de-Wit, Joseph Olley, et al.
Pageof 11